Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Combined actions of zinc and fluoxetine on nicotinic acetylcholine receptors

The Pharmacogenomics Journal volume 4, pages 388–393 (2004)Cite this article

ABSTRACT

Zinc and nicotinic acetylcholine receptors (nAChRs) seem to be associated with major depression, and some antidepressants, including fluoxetine (Prozac), antagonize nAChRs. Therefore, a study was made of the modulation of neuronal α4β4 and muscle α1β1γδ nAChRs, expressing in oocytes, by the combined action of zinc and fluoxetine. At a holding potential of –60 mV, 200 μM zinc increased by 361% the currents elicited by acetylcholine (ACh currents) for α4β4 and by 182% for α1β1γδ nAChRs. In contrast, 5 μM fluoxetine reduced the ACh currents to 31% for α4β4 and to 45% for α1β1γδ nAChRs. Additionally, fluoxetine reduced more the ACh currents in the presence of zinc: to 17% for α4β4 and to 19% for α1β1γδ nAChRs, and after washing out the fluoxetine the ACh current did not recover its zinc-potentiated value. Moreover, when ACh-activated nAChRs were exposed first to fluoxetine and then zinc was added, the potentiating effect of zinc was very small for muscle nAChRs and was nil for neuronal receptors. Thus, the inhibiting effect of fluoxetine prevails over the potentiating action of zinc. Finally, the effects of both zinc and fluoxetine were voltage independent, indicating that these substances interact outside the ion channel. As fluoxetine nullifies the effects of zinc, it appears that both substances interact in the same site. These results should help understand better the roles played by zinc, antidepressants, nAChRs and their combination in brain functions and in the treatment of depression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Levin ED . Nicotinic receptor subtypes and cognitive function. J Neurobiol 2002; 53: 633–640.

    Article  CAS  Google Scholar 

  2. Picciotto MR, Brunzell DH, Caldarone BJ . Effect of nicotine and nicotinic receptors on anxiety and depression. NeuroReport 2002; 13: 1097–1106.

    Article  CAS  Google Scholar 

  3. Vizi ES, Lendvai B . Modulatory role of presynaptic nicotinic receptors in synaptic and non-synaptic chemical communication in the central nervous system. Brain Res Brain Res Rev 1999; 30: 219–235.

    Article  CAS  Google Scholar 

  4. Cockcroft VB, Ortels M, Lunt GG . Ligands, receptor models, and evolution. Ann N Y Acad Sci 1995; 757: 40–47.

    Article  CAS  Google Scholar 

  5. García-Colunga J, Miledi R . Opposite effects of lanthanum on different types of nicotinic acetylcholine receptors. NeuroReport 1997; 8: 3293–3296.

    Article  Google Scholar 

  6. García-Colunga J, González-Herrera M, Miledi R . Modulation of nicotinic acetylcholine receptors by zinc. NeuroReport 2001; 12: 147–150.

    Article  Google Scholar 

  7. Hsiao B, Dweck D, Luetje CW . Subunit-dependent modulation of neuronal nicotinic receptors by zinc. J Neurosci 2001; 21: 1848–1856.

    Article  CAS  Google Scholar 

  8. Palma E, Maggi L, Miledi R, Eusebi F . Effects of Zn2+ on wild and mutant neuronal α7 nicotinic receptors. Proc Natl Acad Sci USA 1998; 95: 10246–10250.

    Article  CAS  Google Scholar 

  9. García-Colunga J . Serotonergic modulation of nicotinic acetylcholine receptors. Synaptic transmission 100 years after Luigi Luciani. Symposium in honour of Ricardo Miledi, Rome, Italy, 2000; pp 43–44.

  10. García-Colunga J, Miledi R . Effects of serotonergic agents on neuronal nicotinic acetylcholine receptors. Proc Natl Acad Sci USA 1995; 92: 2919–2923.

    Article  Google Scholar 

  11. García-Colunga J, Miledi R . Serotonergic modulation of muscle acetylcholine receptors of different subunit composition. Proc Natl Acad Sci USA 1996; 93: 3990–3994.

    Article  Google Scholar 

  12. García-Colunga J, Miledi R . Blockage of mouse muscle nicotinic acetylcholine receptors by serotonergic compounds. Exp Physiol 1999; 84: 847–864.

    Article  Google Scholar 

  13. Grassi F, Polenzani L, Mileo AM, Caratsch CG, Eusebi F, Miledi R . Blockage of nicotinic acetylcholine receptors by 5-hydroxytryptamine. J Neurosci Res 1993; 34: 562–570.

    Article  CAS  Google Scholar 

  14. García-Colunga J, Awad JN, Miledi R . Blockage of muscle acetylcholine receptors by the serotonin 1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Biomed Res 1997; 18: 307–311.

    Article  Google Scholar 

  15. Fryer JD, Lukas RJ . Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function. J Neurochem 1999; 72: 1117–1124.

    Article  CAS  Google Scholar 

  16. García-Colunga J, Awad JN, Miledi R . Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac). Proc Natl Acad Sci USA 1997; 94: 2041–2044.

    Article  Google Scholar 

  17. Hennings ECP, Kiss JP, De Oliveira K, Toth PT, Vizi ES . Nicotinic acetylcholine receptor antagonism activity of monoamine uptake blockers in rat hippocampal slices. J Neurochem 1999; 73: 1043–1050.

    Article  CAS  Google Scholar 

  18. López-Valdés H, García-Colunga J . Antagonism of nicotinic acetylcholine receptors by inhibitors of monoamine uptake. Mol Psychiatry 2001; 6: 511–519.

    Article  Google Scholar 

  19. López-Valdés HE, García-Colunga J, Miledi R . Effects of clomipramine on neuronal nicotinic acetylcholine receptors. Eur J Pharmacol 2002; 444: 13–19.

    Article  Google Scholar 

  20. Maggi L, Palma E, Miledi R, Eusebi F . Effects of fluoxetine on wild and mutant neuronal α7 nicotinic receptors. Mol Psychiatry 1998; 3: 350–355.

    Article  CAS  Google Scholar 

  21. Shytle RD, Silver AA, Lukas RJ, Newman MB, Sheehan DV, Sanberg PR . Nicotinic acetylcholine receptors as targets for antidepressants. Mol Psychiatry 2002; 7: 525–535.

    Article  CAS  Google Scholar 

  22. Frederickson CJ, Suh SW, Silva D, Frederickson CJ, Thompson RB . Importance of zinc in the central nervous system: the zinc-containing neuron. J Nutr 2000; 130 (Suppl): 1471S–1483S.

    Article  CAS  Google Scholar 

  23. Birinyi A, Parker D, Antal M, Shupliakov O . Zinc co-localizes with GABA and glycine in synapses in the lamprey spinal cord. J Comp Neurol 2001; 433: 208–221.

    Article  CAS  Google Scholar 

  24. Howell GA, Welch MG, Frederickson CJ . Stimulation-induced uptake and release of zinc in hippocampal slices. Nature 1984; 308: 736–738.

    Article  CAS  Google Scholar 

  25. Assaf SY, Chung SH . Release of endogenous Zn2+ from brain tissue during activity. Nature 1984; 308: 734–736.

    Article  CAS  Google Scholar 

  26. Harrison NL, Gibbons SJ . Zn2+: an endogenous modulator of ligand- and voltage-gated ion channels. Neuropharmacology 1994; 33: 935–952.

    Article  CAS  Google Scholar 

  27. Maes M, Vandoolaeghe E, Neels H, Demedts P, Wauters A, Meltzer HY et al. Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry 1997; 42: 349–358.

    Article  CAS  Google Scholar 

  28. Nowak G, Szewczyk B . Mechanisms contributing to antidepressant zinc actions. Pol J Pharmacol 2002; 54: 587–592.

    CAS  PubMed  Google Scholar 

  29. Nowak G, Szewczyk B, Sadlik K, Piekoszewski W, Trela F, Florek E et al. Reduced potency of zinc to interact with NMDA receptors in hippocampal tissue of suicide victims. Pol J Pharmacol 2003; 55: 455–459.

    CAS  PubMed  Google Scholar 

  30. Nowak G, Szewczyk B, Wieronska JM, Branski P, Palucha A, Pilc A et al. Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Res Bull 2003; 61: 159–164.

    Article  CAS  Google Scholar 

  31. Rosa AO, Lin J, Calixto JB, Santos AR, Rodrigues AL . Involvement of NMDA receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. Behav Brain Res 2003; 144: 87–93.

    Article  CAS  Google Scholar 

  32. Kroczka B, Branski P, Palucha A, Pilc A, Nowak G . Antidepressant-like properties of zinc in rodent forced swim test. Brain Res Bull 2001; 55: 297–300.

    Article  CAS  Google Scholar 

  33. Nowak G, Siwek M, Dudek D, Zieba A, Pilc A . Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Pol J Pharmacol 2003; 55: 1143–1147.

    Article  CAS  Google Scholar 

  34. Wong DT, Bymaster FP, Engleman EA . Prozac (Fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci 1995; 57: 411–441.

    Article  CAS  Google Scholar 

  35. Popik P, Kozela E, Krawczyk M . Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram. Br J Pharmacol 2003; 139: 1196–1202.

    Article  CAS  Google Scholar 

  36. Sharma G, Vijayaraghavan S . Modulation of presynaptic store calcium induces release of glutamate and postsynaptic firing. Neuron 2003; 38: 929–939.

    Article  CAS  Google Scholar 

  37. Goodnick PJ . Pharmacokinetics of second generation antidepressants: fluoxetine. Psychopharmacol Bull 1991; 27: 503–512.

    CAS  PubMed  Google Scholar 

  38. Karson CN, Newton JE, Livingston R, Jolly JB, Cooper TB, Sprigg J et al. Human brain fluoxetine concentrations. J Neuropsychiatry Clin Neurosci 1993; 5: 322–329.

    Article  CAS  Google Scholar 

  39. Nowak G, Schlegel-Zawadzka M . Alterations in serum and brain trace element levels after antidepressant treatment: Part I. Zinc. Biol Trace Elem Res 1999; 67: 85–92.

    Article  CAS  Google Scholar 

  40. Szewczyk B, Branski P, Wieronska JM, Palucha A, Pilc A, Nowak G . Interaction of zinc with antidepressants in the forced swimming test in mice. Pol J Pharmacol 2002; 54: 681–685.

    Article  CAS  Google Scholar 

  41. Miledi R, Woodward RM . Effects of defolliculation on membrane current responses of Xenopus oocytes. J Physiol (Lond) 1989; 416: 601–621.

    Article  CAS  Google Scholar 

  42. Miledi R . A calcium-dependent transient outward current in Xenopus laevis oocytes. Proc R Soc Lond 1982; B215: 491–497.

    Google Scholar 

Download references

Acknowledgements

We are grateful to Drs J Boulter and S Heinemann (the Salk Institute) for providing the nicotinic acetylcholine receptor clones. This work was supported by Grants from the Consejo Nacional de Ciencia y Tecnología, México 35033-N (to JGC), G25775N (to JGC and RM), a CONACYT scholarship (to EVG) and by a National Science Foundation (Neuronal and Glial Mechanisms) Grant 998285 (to RM).

Author information

Authors and Affiliations

  1. Instituto de Neurobiología, Universidad Nacional Autónoma de México, Campus Juriquilla, Querétaro, México

    J García-Colunga, E Vázquez-Gómez & R Miledi

  2. Department of Neurobiology and Behavior, Laboratory of Cellular and Molecular Neurobiology, University of California, Irvine, CA, USA

    R Miledi

Authors
  1. J García-Colunga
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E Vázquez-Gómez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R Miledi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J García-Colunga.

Additional information

DUALITY OF INTEREST

None declared.

Rights and permissions

Reprints and permissions

About this article

Cite this article

García-Colunga, J., Vázquez-Gómez, E. & Miledi, R. Combined actions of zinc and fluoxetine on nicotinic acetylcholine receptors. Pharmacogenomics J 4, 388–393 (2004). https://doi.org/10.1038/sj.tpj.6500275

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.tpj.6500275

Keywords

This article is cited by

Search

Advanced search

Quick links